Abstract
Hemoglobinopathies, such as β-thalassemia and sickle cell disease (SCD), are among the most common congenital diseases in the world, with high mortality and morbidity rates. The most straightforward approach to correct the main culprit in hemoglobinopathies - the imbalance between the amounts of alpha-like globins/betalike globins- will need to target directly the gene structure or their regulatory elements in order to obtain a sustained therapeutic effect.
Finding effective methods to deliver the genetic “blueprints” of the correct and functional protein or, even better, the “DNA repairing kit” able to do the job in situ, remains a major challenge, despite the fact that gene therapy is already used in different diseases. Members of several viral families were employed as “Trojan horses” using the virus ability to deliver a modified genetic material inside the cell and to manipulate the host replication machinery to produce the encoded proteins. Recently, non-viral vectors are gaining advantages for genome correction, especially after the exponential development of the genome editing approaches that can provide precise in situ modifications. This review summarizes the recent advances in the viral and non-viral delivery strategies and emphasizes the therapeutic potential of different approaches designed to correct the genetic defects responsible for the most common hemoglobinopathies.Keywords: Genetic therapy, nucleic acids delivery strategies, hemoglobinopathies, DNA repairing, DNA editing, viral and non-viral vectors, nanoparticles.
Current Organic Chemistry
Title:Delivering the "Blueprints" or "DNA Repairing Kits" Instead of Drugs in the Treatment of Congenital Hemoglobinopathies
Volume: 21 Issue: 1
Author(s): Diana Chiru, Cristina Mambet, Lilia Matei, Coralia Bleotu, Simona Ruta and Carmen C. Diaconu
Affiliation:
Keywords: Genetic therapy, nucleic acids delivery strategies, hemoglobinopathies, DNA repairing, DNA editing, viral and non-viral vectors, nanoparticles.
Abstract: Hemoglobinopathies, such as β-thalassemia and sickle cell disease (SCD), are among the most common congenital diseases in the world, with high mortality and morbidity rates. The most straightforward approach to correct the main culprit in hemoglobinopathies - the imbalance between the amounts of alpha-like globins/betalike globins- will need to target directly the gene structure or their regulatory elements in order to obtain a sustained therapeutic effect.
Finding effective methods to deliver the genetic “blueprints” of the correct and functional protein or, even better, the “DNA repairing kit” able to do the job in situ, remains a major challenge, despite the fact that gene therapy is already used in different diseases. Members of several viral families were employed as “Trojan horses” using the virus ability to deliver a modified genetic material inside the cell and to manipulate the host replication machinery to produce the encoded proteins. Recently, non-viral vectors are gaining advantages for genome correction, especially after the exponential development of the genome editing approaches that can provide precise in situ modifications. This review summarizes the recent advances in the viral and non-viral delivery strategies and emphasizes the therapeutic potential of different approaches designed to correct the genetic defects responsible for the most common hemoglobinopathies.Export Options
About this article
Cite this article as:
Chiru Diana, Mambet Cristina, Matei Lilia, Bleotu Coralia, Ruta Simona and Diaconu C. Carmen, Delivering the "Blueprints" or "DNA Repairing Kits" Instead of Drugs in the Treatment of Congenital Hemoglobinopathies, Current Organic Chemistry 2017; 21 (1) . https://dx.doi.org/10.2174/1385272820666160511122404
DOI https://dx.doi.org/10.2174/1385272820666160511122404 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Targets to Promote Central Nervous System Regeneration
Current Neurovascular Research Programmed Cell Death in Plants: Insights into Developmental and Stress-Induced Cell Death
Current Protein & Peptide Science Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Nutritional Targeting of Cyclooxygenase-2 for Colon Cancer Prevention
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Docking, 3D-QSAR and Structural Optimization of Indole Biphenylcarboxylic Acids as PPARγ Antagonists
Letters in Drug Design & Discovery New Insights in Mast Cell Modulation by Palmitoylethanolamide
CNS & Neurological Disorders - Drug Targets Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Medical and Societal Impact
Current Immunology Reviews (Discontinued) Editorial [Hot Topic: Non-Invasive Delivery of iRNAs, Proteins, Peptides, Cytokines and Nanoparticles (Guest Editor: Bingmei M. Fu)]
Current Pharmaceutical Biotechnology Regulation of Neural Stem Cells in the Human SVZ by Trophic and Morphogenic Factors
Current Signal Transduction Therapy LPS In Patients With Left Ventricular Dysfunction Of Ischemic And Non-Ischemic Origin
Cardiovascular & Hematological Disorders-Drug Targets Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
Current Pharmaceutical Design Nitric Oxide and Pancreatic Cancer Pathogenesis, Prevention, and Treatment
Current Pharmaceutical Design The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies
Central Nervous System Agents in Medicinal Chemistry Protein Kinases as Small Molecule Inhibitor Targets in Inflammation
Current Medicinal Chemistry Editorial [Hot Topic: Mitochondria as a Pharmacological Target: A Clue for Efficacy and a Reason for Toxicity (Executive Guest Editor: Nadezda Apostolova)]
Current Pharmaceutical Design Co-culture and Mechanical Stimulation on Mesenchymal Stem Cells and Chondrocytes for Cartilage Tissue Engineering
Current Stem Cell Research & Therapy The Interaction of Dietary Fibres with the Colon
Current Nutrition & Food Science Periodontitis and Atherosclerosis, a Causal Relationship?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Human Cognitive and Neuro-Psychiatric Bio-Markers in the Cardiac Peri-Operative Patient
Current Molecular Medicine